GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (OSTO:CANTA) » Definitions » 3-Year EBITDA Growth Rate

Cantargia AB (OSTO:CANTA) 3-Year EBITDA Growth Rate : -1.00% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cantargia AB 3-Year EBITDA Growth Rate?

Cantargia AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.20.

During the past 3 years, the average EBITDA Per Share Growth Rate was -1.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -15.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cantargia AB was 17.00% per year. The lowest was -69.80% per year. And the median was -32.20% per year.


Competitive Comparison of Cantargia AB's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Cantargia AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantargia AB's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantargia AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cantargia AB's 3-Year EBITDA Growth Rate falls into.



Cantargia AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Cantargia AB  (OSTO:CANTA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Cantargia AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cantargia AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantargia AB (OSTO:CANTA) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.

Cantargia AB (OSTO:CANTA) Headlines

No Headlines